Beta-cell preservation…Is weight loss the answer?

The Review of Diabetic Studies : RDS
Angela D MazzaSteven R Smith

Abstract

Obesity is associated with an increased risk of type 2 diabetes (T2D). Pancreatic beta-cell failure is an early event in the development of glucose dysregulation and diabetes. Interventions to halt beta-cell failure in T2D include diet modification, exercise, and use of pharmacologic agents. There is evidence that abdominal obesity may contribute to diabetes through insulin resistance and beta-cell impairment. Pivotal long-term studies into the prevention of T2D have shown the importance of weight loss beside diet, lifestyle, and medication. The Finnish Diabetes Prevention Program (DPP) showed that weight loss gradually reduces the risk of diabetes, and that even modest weight loss can significantly reduce the incidence of T2D. Similarly, in the US DPP, weight loss as part of intensive lifestyle modification was the major factor in reducing the incidence of T2D in high-risk subjects, being more effective than drug intervention. While understanding the relationship between obesity and diabetes is complex, we know that weight loss has positive effects on adipose tissue. It causes an increase in the beneficial fat cell hormone adiponectin, and a decrease in adipose tissue inflammation. Also, it is associated with reduced insulin r...Continue Reading

References

Sep 24, 2004·Diabetes/metabolism Research and Reviews·Itamar RazEleazar Shafrir
May 27, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H-P KoppG Schernthaner
Aug 29, 2006·Diabetes Care·Richard F HammanJudith Wylie-Rosett
Jul 22, 2008·Diabetes & Metabolism·P-J GuillausseauJ-P Kevorkian
Dec 17, 2009·Diabetes Care·Anthony J HanleyUNKNOWN Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators
Mar 17, 2010·The New England Journal of Medicine·Rury R HolmanRobert M Califf
Mar 25, 2011·The New England Journal of Medicine·Ralph A DeFronzoUNKNOWN ACT NOW Study
Apr 28, 2011·Current Opinion in Endocrinology, Diabetes, and Obesity·Richard A Perugini, Samir Malkani
Nov 15, 2011·Diabetes, Obesity & Metabolism·A J Garber

❮ Previous
Next ❯

Citations

Oct 18, 2018·Expert Review of Endocrinology & Metabolism·Donald A Williamson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

The New England Journal of Medicine
David M Nathan
The Medical Clinics of North America
A Ramachandran, C Snehalatha
Current Diabetes Reports
Jocelyne G Karam, Samy I McFarlane
© 2021 Meta ULC. All rights reserved